Kolon Life Science Inc. (KOSDAQ:102940)
63,800
-1,200 (-1.85%)
At close: Feb 27, 2026
138.06% (1Y)
| Market Cap | 833.41B |
| Revenue (ttm) | 211.13B |
| Net Income (ttm) | 17.80B |
| Shares Out | 13.06M |
| EPS (ttm) | 1,290.73 |
| PE Ratio | 49.43 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 53,616 |
| Average Volume | 60,538 |
| Open | 66,100 |
| Previous Close | 65,000 |
| Day's Range | 63,000 - 66,400 |
| 52-Week Range | 23,500 - 72,700 |
| Beta | 0.06 |
| RSI | 58.34 |
| Earnings Date | Mar 19, 2026 |